Observational registry for patients treated with GORE® endovascular devices for abdominal aortic aneurysms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects real-world data on patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis. The study aims to follow patients for up to 10 years post-procedure to assess outcomes and any issues related to the devices. Patient selection and treatment interventions will be determined by physicians based on standard clinical practice, ensuring that the data reflects routine care. Participants will attend regular follow-up visits and report any concerns to their healthcare providers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements
2. Patient has been or is intended to be treated with an eligible registry device
3. Patient is age ≥ 18 years at time of informed consent signature.

Exclusion Criteria:

1. Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures.
2. Patient with exclusion criteria required by local law.
3. Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol.

Where it's running

• Central Arkansas Veteran's Healthcare System
  Little Rock, Arkansas, United States Recruiting
• University of California - Irvine
  Irvine, California, United States Recruiting
• University of Southern California
  Los Angeles, California, United States Recruiting
• University of Southern California
  Los Angeles, California, United States Recruiting
• Stanford University School of Medicine
  Palo Alto, California, United States Recruiting
• Stanford University School of Medicine
  Stanford, California, United States Recruiting

+40 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Principal investigator: S. Han — University of Southern California
• Study coordinator: Karen Martin
• Email: kgmartin@wlgore.com
• Phone: 928-864-2223

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heli-FX EndoAnchor system in abdominal aortic aneurysm patients in China

  This study tests whether the Heli-FX EndoAnchor device can safely and effectively help seal and fix AAA patients at high risk of endoleaks or migration after repair.

  Recruiting Medtronic Cardiovascular · Beijing · NCT07754318

• TUVA BX and iCover stent grafts used in BEVAR for complex aortic aneurysms

  This study looks at whether the TUVA BX and iCover stent grafts used during BEVAR procedures are safe and perform well in real-world patients with complex abdominal or thoracoabdominal aneurysms.

  Recruiting JOTEC GmbH · Heerlen · NCT07540507

• Retreatment with the Nectero EAST System for abdominal aortic aneurysm

  This will try retreatment with the Nectero EAST System to repair infrarenal abdominal aortic aneurysms in adults who previously received the device under the initial protocol.

  Recruiting at 2 sites Nectero Medical, Inc. · Randwick, New South Wales and 1 other locations · NCT07505082

• Abdominal CT offered alongside lung screening for people who have smoked

  We will test whether mentioning a possible extra abdominal CT in the lung screening invitation changes whether people aged 55–70 who have ever smoked attend their lung screening appointment.

  Recruiting University of Cambridge · Hull · NCT07171190

• Evaluating outcomes of endovascular abdominal aortic aneurysm repair

  This study is testing two different devices for repairing abdominal aortic aneurysms to see which one works better for patients over time.

  Recruiting at 25 sites Endologix · Huntsville, Alabama and 28 other locations · NCT05064540

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.